Skip to content

Efficacy of Thiamine in Amnisia due to Electro Convulsive Therapy

Effectiveness of Thiamine on Cognitive Performance of Paitients Under Electro-Convulsive Therapy: A Randomized Double Blind Clinical Trial.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191218045795N4
Enrollment
70
Registered
2020-05-03
Start date
2020-02-29
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia,Schizoaffective,Mood dosorders and Obsessive-compulsive disorders. Schizophrenia ,Schizoaffective disorder.Bipolar affective disoeder.Obssessive_compulsive disorder,Mood disorder(manic episode).Mood disorder(Depressive episode)

Interventions

Intervention 1: Intervention group: Thiamine 100 mg capsul Twice a day(morning & night) in the intervention group. Intervention 2: Intervention group:.

Sponsors

Sanandaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients candicate for ECT ; Age between 18-60 years old. The Patient or his or her legal guardian must sign the informed consent form. The number of Electro Convulsive Therapy sessions ; must be between 2-12 sessions.

Exclusion criteria

Exclusion criteria: Alcohol and substance dependence except Caffeine and Nicotine in past 3 months. Proven Intelligent Disability or diagnosed with assistant. History of Delirium, Dementia and Cognitive Disorders. History of Thiamine consumption from 3 months before the visit. History of Thiamine sensitivity.

Design outcomes

Primary

MeasureTime frame
Memory. Timepoint: 1day before begining and after ending the Electro Convulsive Therapy. Method of measurement: wechsler.;Memory. Timepoint: 1day before begining and after ending the Electro Convulsive Therapy. Method of measurement: mini mental status examination.

Secondary

MeasureTime frame
Tremor. Timepoint: During the intervention. Method of measurement: Patient Self Report.;Cofusion. Timepoint: During the intervention. Method of measurement: Patient Self Report.;Headache. Timepoint: During the intervention. Method of measurement: Patient Self Report.;Nausea. Timepoint: During the intervention. Method of measurement: Patient Self Report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNarges Shamsalizadeh

Sanandaj University of Medical Sciences

n.shamsalizadeh@muk.ac.ir+98 912 159 9112

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026